[NUProtein Co., Ltd.] NUProtein Co., Ltd. Innovative technology licensing program “GenesCIS Elements and
Announcing “Methods”
*NU Protein Co., Ltd.*
Press release: August 27, 2024
**
NUProtein Co., Ltd. announces innovative technology licensing program “GenesCIS Elements and Methods”
*Share knowledge and carve a sustainable future together*
*August 27, 2024, Awaji Island* –
NU Protein Co., Ltd., a leader in innovation in plant-derived functional proteins, today announced the launch of a new technology licensing program, GenesCIS.
Elements and
We are pleased to announce the launch of “Methods”. This program aims to widely publicize cell-free protein synthesis technology derived from wheat germ and foster innovation in the cultured meat industry and biochemical reagent fields.
* “Towards a world where everyone can have access to the future of functional proteins” *
This new technology licensing program developed by NUProtein provides an environment where any company or researcher can easily synthesize functional proteins such as growth factors. In particular, we will support the acceleration of industry in the field of cultured meat, and in the field of biochemical reagents, we will create an
environment where researchers can quickly and inexpensively use the proteins of their interest.
The latest report from US Roots Analysis, “Cell Free System Market: Cell Free Expression Kits”
and Service Providers,
According to 2023-2035 (2023 edition), the cell-free protein synthesis market is expected to reach approximately $275 million in 2023 and grow at a compound annual growth rate (CAGR) of 7.1% by 2035. . The report also comprehensively investigates patents related to cell-free protein synthesis technology filed from 2015 to 2023, and ranks NUProtein as one of the top five companies in terms of patents. In this program, we will release these important patents acquired by NUProtein and provide them with know-how.
The program consists of two options: a short-term evaluation license and a commercial license. Evaluation licenses are intended for technology evaluation and test use, while commercial licenses support commercial use. These licenses include the reagent composition and extraction method for extracting the protein translation apparatus from wheat germ, the method for producing the amino acid mixture necessary for the translation reaction, and the optimized gene sequences of two types of functional proteins. and related
intellectual property licenses.
Additionally, the commercial license includes an optional gene optimization service using high-expression gene design technology provided by Nara Institute of Science and Technology. This service will enable commercial users to more cost-effectively synthesize various functional proteins such as bovine growth factor in a non-GMO environment using edible wheat germ as a starting material.
* “Sharing knowledge and opening up the future” *
NUProtein is open to the public with knowledge based on past research and technology, and is looking for partners to co-create the future of industry. Through this innovative licensing program, we are
transforming a new era of meat production and biochemical research to be more sustainable and efficient.